103 related articles for article (PubMed ID: 23362288)
1. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting.
Lloyd AR; Clegg J; Lange J; Stevenson A; Post JJ; Lloyd D; Rudge G; Boonwaat L; Forrest G; Douglas J; Monkley D
Clin Infect Dis; 2013 Apr; 56(8):1078-84. PubMed ID: 23362288
[TBL] [Abstract][Full Text] [Related]
2. Enhancing assessment and treatment of hepatitis C in the custodial setting.
Post JJ; Arain A; Lloyd AR
Clin Infect Dis; 2013 Aug; 57 Suppl 2():S70-4. PubMed ID: 23884069
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of treatment for hepatitis C in prisoners using a nurse-led, statewide model of care.
Papaluca T; McDonald L; Craigie A; Gibson A; Desmond P; Wong D; Winter R; Scott N; Howell J; Doyle J; Pedrana A; Lloyd A; Stoove M; Hellard M; Iser D; Thompson A
J Hepatol; 2019 May; 70(5):839-846. PubMed ID: 30654067
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of a nurse-led model of care for hepatitis C assessment and treatment with direct-acting antivirals in the custodial setting.
Overton K; Clegg J; Pekin F; Wood J; McGrath C; Lloyd A; Post JJ
Int J Drug Policy; 2019 Oct; 72():123-128. PubMed ID: 30967329
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
Sterling RK; Brown RS; Hofmann CM; Luketic VA; Stravitz RT; Sanyal AJ; Contos MJ; Mills AS; Smith V; Shiffman ML
Am J Gastroenterol; 2005 Feb; 100(2):313-21. PubMed ID: 15667488
[TBL] [Abstract][Full Text] [Related]
6. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
7. Treatment for hepatitis C virus infection among current injection drug users in Australia.
Matthews G; Kronborg IJ; Dore GJ
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S325-9. PubMed ID: 15768342
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C in Australian prisons: a national needs assessment.
Mina MM; Herawati L; Butler T; Lloyd A
Int J Prison Health; 2016; 12(1):3-16. PubMed ID: 26933988
[TBL] [Abstract][Full Text] [Related]
9. Bipolar patients can safely and successfully receive interferon-based hepatitis C antiviral treatment.
Kelly EM; Corace K; Emery J; Cooper CL
Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):811-6. PubMed ID: 22495398
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
[TBL] [Abstract][Full Text] [Related]
11. Advances in the treatment of hepatitis C.
Lawrence SP
Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
[TBL] [Abstract][Full Text] [Related]
12. Telementoring for hepatitis C treatment in correctional facilities.
Neuhaus M; Langbecker D; Caffery LJ; Taylor M; Garner L; Williams G; Smith AC; Macdonald GA
J Telemed Telecare; 2018 Dec; 24(10):690-696. PubMed ID: 30343659
[TBL] [Abstract][Full Text] [Related]
13. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
[TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of antiviral therapy in patients with chronic hepatitis C treated by private practice gastroenterologists].
Hofmann WP; Bock H; Weber C; Tacke W; Pfaff R; Kihn R; Moog G; Kellner HU; Schöfer M; Frick B; Berg P; Rambow A; Friedrich-Rust M; Herrmann E; Sarrazin C; Zeuzem S
Z Gastroenterol; 2006 Jan; 44(1):25-31. PubMed ID: 16397836
[TBL] [Abstract][Full Text] [Related]
15. Addressing viral hepatitis in the opiate substitution setting: an integrated nursing model of care.
Fragomeli V; Weltman M
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 2():6-11. PubMed ID: 25641224
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.
Galun E; Terrault NA; Eren R; Zauberman A; Nussbaum O; Terkieltaub D; Zohar M; Buchnik R; Ackerman Z; Safadi R; Ashur Y; Misrachi S; Liberman Y; Rivkin L; Dagan S
J Hepatol; 2007 Jan; 46(1):37-44. PubMed ID: 17112624
[TBL] [Abstract][Full Text] [Related]
17. Use of telehealth to increase treatment access for prisoners with chronic hepatitis C.
Halder A; Li VG; Sebastian M; Nazareth S; Tuma R; Cheng W; Doyle A
Intern Med J; 2021 Aug; 51(8):1344-1347. PubMed ID: 34423535
[TBL] [Abstract][Full Text] [Related]
18. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
[TBL] [Abstract][Full Text] [Related]
19. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response.
Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P
Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
